WMG Financial Advisors’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History
Bought
Maintained
Sold
Other funds holding FTXH
MIM
AIP
OMC
PAG
VCM
OIA
WMG Financial Advisors's FTXH Position: Q4 2025 in Review
WMG Financial Advisors sold out of First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q4 2025, closing a stake of 10,726 shares — an estimated $306K sold.
WMG Financial Advisors first reported a position in FTXH in Q2 2022 and held it in 14 quarters. The position peaked at $1.34M in Q1 2023. 26 funds tracked by Wall St. Rank hold FTXH as of Q4 2025.
- WMG Financial Advisors reported no remaining First Trust Nasdaq Pharmaceuticals ETF position as of Q4 2025 after selling out during the quarter.
- WMG Financial Advisors sold 10,726 First Trust Nasdaq Pharmaceuticals ETF shares in Q4 2025, an estimated $306K.
- WMG Financial Advisors first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q2 2022 and held it in 14 quarters.
- WMG Financial Advisors's First Trust Nasdaq Pharmaceuticals ETF position peaked at $1.34M in Q1 2023.
- 26 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q4 2025.
Based on WMG Financial Advisors's 13F filing for Q4 2025, filed 28 Jan 2026.